VSV-EBOPLUS consortium pleased to invite you to the online VSV-EBOPLUS Conference on “Systems analysis of adult and pediatric responses to the VSV-ZEBOV Ebola vaccine”, that…
The VSV-EBOPLUS final meeting will be organized in Camogli (Genova, Italy), at the Cenobio dei Dogi hotel on the 27-29 March 2023. The organization will…
The VSV-EBOPLUS annual meeting 2022 was held in Camogli on 26-28 September. Representatives of each Institution have attended the meeting, presenting and discussing the results…
Health authorities in Guinea declared an outbreak of Ebola in the rural community of Gouéké in N’Zerekore prefecture after three Ebola cases were confirmed by the national laboratory, marking…
The four leading international health and humanitarian organizations announced the establishment of a global Ebola vaccine stockpile to ensure outbreak response. The effort to establish…
The VSV-EBOPLUS scientist Helder Nakaya has been recognized as one of the Highly Cited Researchers 2020 and as a true pioneer in the field of…
Due to the COVID-19 crisis, the VSV-EBOPLUS Project meeting 2020 was held as online meeting on 21st and 22nd September 2020. Representatives of each Institution…
The U.S. Food and Drug Administration announced today the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused…
The World Health Organization (WHO) today prequalified an Ebola vaccine for the first time, a critical step that will help speed up its licensing, access…